Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunotherapy
>>
Phase 3
«
1
2
...
3
4
5
6
7
8
9
10
11
12
13
14
15
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
33
66
99
132
165
198
231
264
297
330
recombinant herpes zoster vaccine
(CHO Cells) / MaxHealth Biotech
resatorvid
(TAK-242) / Takeda, Akaza Bioscience
rituximab biosimilar
(TL011) / Teva
surzebiclimab
(BGB-A425) / BeiGene
tyroserleutide
(CMS024) / China Medical System
ADM03820
/ Resilience
AV-GBM-1
/ AiVita Biomedical
AZD2816
/ AstraZeneca, University of Oxford
AdCLD-CoV19-1 OMI
/ Cellid
Adalimumab BS MA
(adalimumab biosimilar) / Mochida, LG Chem, Daewoong Pharma
Anti-SARS-CoV-2 equine immunoglobulin formulation
/ University of Costa Rica
BA1104
(nivolumab biosimilar) / Luye Group
BIBP Omicron Inactivated COVID-19 vaccine
(Vero Cell) / Sinopharm
BNT162b2s01
/ Pfizer, BioNTech, Fosun Pharma
BiovaxID
(dasiprotimut-T) / National Cancer Institute, Accentia
Bioven
(intravenous immunogloblin) / Biopharma Plasma
Bmab1200
(ustekinumab biosimilar) / Biocon, Yoshindo
Brilife
(IIBR-100) / Israel Institute for Biological Research
C19-IG 20%
/ Grifols
C3BS-CQR-1
/ Celyad Oncology
CC-700C
/ TCM Biotech
CT-P63
/ Celltrion
CardiAMP Cell Therapy
(BCDA-01) / BioCardia
CimetrA
/ MGC Pharma
CinnoRA
(adalimumab biosimilar) / CinnaGen
Clade C and Mosaic gp140 HIV bivalent vaccine
/ J&J
Convacell
/ St. Petersburg Scientific Research Institute of Vaccines and Serums
Convalescent Plasma
/ Hamilton Health Sciences Corporation
Convalescent Plasma for COVID-19
/ Del Rosario University
Convalescent plasma therapy
/ Columbia University
Convalescent plasma therapy
/ Institute of Liver and Biliary Sciences
CoviFab
(equine hyperimmune serum) / Inmunova
DTaP-IPV combination vaccine
/ Boryung Group
Dalibra
(adalimumab biosimilar) / Biocad
Delito
(rituximab biosimilar) / Sino Biopharm
Enerceptan
(etanercept biosimilar) / AMEGA Biotech
Enkorten
(metenkefalin/tridecactide) / Bosnalijek
Envacgen
(inactivated EV71 vaccine) / Medigen Biotech
F0024
/ Shanghai Fudan-Zhangjiang
F007
(rituximab biosimilar) / Lunan Pharma
FYB206
(pembrolizumab biosimilar) / Formycon
GB241
(rituximab biosimilar) / Nanjing Yoko Biomedical, Walvax
GC3107
/ GC Biopharma
GRAd-COV2
/ ReiThera, Leukocare, Univercells
Gamma Variant RBD-based ARVAC-CG vaccine
/ National University of San Martin, National Scientific and Technical Research Council, Pablo Cassara
Green Cross TD Vaccine
(GC1107) / GC Biopharma
Grippol
/ NPO Petrovax
HS016
(adalimumab biosimilar) / Zhejiang Hisun
Halpryza
(rituximab biosimilar) / Innovent Biologics, Eli Lilly
Handayuan
(adalimumab biosimilar) / Fosun Pharma, Getz Pharma
«
1
2
...
3
4
5
6
7
8
9
10
11
12
13
14
15
»
